Neurocrine Biosciences Inc. Announcements

Neurocrine Biosciences Inc. has made several announcements in recent weeks. The company will present at two investor conferences in May, with its CEO and CFO presenting updates on the company’s latest developments.

Upcoming Investor Conferences

• The company will present at the following investor conferences in May:
  • Conference 1: [Date] at Location
  • Conference 2: [Date] at Location
• The CEO and CFO will present updates on the company’s latest developments.

Analyst Ratings

• Analysts have maintained a buy rating on the company.
• The price target has been raised.

Q1 2025 Earnings Call

• The company’s Q1 2025 earnings call highlighted strong sales of its INGREZZA product.
• The company reaffirmed its sales guidance.

New Awareness Campaign

• Neurocrine Biosciences has launched a new awareness campaign for people with tardive dyskinesia.
• The campaign aims to raise awareness about the condition and solidify the company’s commitment to addressing neurological disorders.

Stock Performance

• The company’s stock has surged in response to the announcements.
• The increase in stock value reflects investor confidence in the company’s growth prospects.